The medtech industry’s most trusted source for news and analysis. Delivering news, revealing insights straight to your inbox.
Washington, DC
Joined January 2010
- Tweets11.3K
- Following162
- Followers15.3K
- Likes277
Stryker is betting $400 million on robotic-assisted surgery through a new deal with CMR Surgical. The agreement gives Stryker exclusive U.S. sales rights to CMR's Versius robots and an option to acquire the company. fiercebiotech.com/medtech/st…
Agilent Technologies is buying up the digital pathology software company Proscia in an all-cash transaction valued at $240 million with an additional $30 million on the cards for future performance milestones. fiercebiotech.com/medtech/ag…
Click Therapeutics has nabbed FDA approval for its digital therapeutic Motivista, which now becomes the first authorized treatment for negative schizophrenia symptoms. fiercebiotech.com/medtech/me…
Abbott has been given U.S. clearance for new updates to its CardioMEMS HF System that allow for patient-facing capabilities through its CardioGuide HF App. fiercebiotech.com/medtech/ab…
Roche's Genentech inks $1.5B bispecific pact with fast-rising Earendil fiercebiotech.com/biotech/ge…
Sofinnova Partners raised $93.3 million in an oversubscribed financing round. The European venture capital group said it will use the cash to expand its medtech creation strategy in Europe and the U.S. fiercebiotech.com/medtech/vc…
Fierce Medtech retweeted
Boehringer Ingelheim and AI drug discovery company Envisagenics have agreed to a potential $1 billion multi-year pact that will task Boehringer with validating tumor-specific targets. fiercebiotech.com/biotech/bo…
Siemens Healthineers is joining forces with Novo to help boost awareness and diagnosis of fatty liver disease. fiercebiotech.com/medtech/si…
FDA clears Aptitude’s latest Metrix molecular dx to test for COVID fiercebiotech.com/medtech/fd…
The FDA cleared Medtronic’s LigaSure vessel sealer-divider to be used in combination with the device maker’s Hugo robotic-assisted surgery system. fiercebiotech.com/medtech/me…
The FDA has signed off on the first-ever glioma drug imaging diagnostic more than a year after it initially rejected the med. fiercebiotech.com/medtech/af…
Abbott received FDA clearance for its latest-generation catheter, which gives physicians more flexibility in treating atrial fibrillation. fiercebiotech.com/medtech/ab…
Medtech and testing giant Labcorp has bought out MLM Medical Labs to help grow its geographic footprint for laboratory services. fiercebiotech.com/medtech/la…
The 2026 Fierce 50 is live.
This year’s honorees include people and organizations using new technologies, diagnostics, data and care models to change how diseases are detected, treated and managed.
See the full Fierce 50: fiercepharma.com/collection/…
Labcorp is looking to plug the gap in hepatitis D monitoring with a new reflex testing solution to help find more patients with this form of the virus earlier. fiercebiotech.com/medtech/la…
Roche has been given an extended clearance by the FDA for its tests that can find patients eligible to use Jazz Pharmaceuticals’ oncology med Ziihera. fiercebiotech.com/medtech/ro…
Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test fiercebiotech.com/medtech/ro…
The FDA has signed off on Implantica’s gastroesophageal reflux disease implant as the medtech eyes a lucrative U.S. market. fiercebiotech.com/medtech/im…
Fierce Medtech retweeted
Today on “The Top Line”: Regeneron Genetics Center’s Andy Deubler sits down with Fierce’s Fraiser Kansteiner to discuss how RGC’s massive genetics database is helping validate drug targets, what sets its data apart and how it could play a role in AI-powered drug development. omny.fm/shows/the-top-line/a…
After 15 years with Medtronic’s structural heart franchise, Bill Shields is leaving the medtech to become the chief exec of startup Versa Vascular. fiercebiotech.com/medtech/me…
